Treeway
Inez de Greef-van der Sandt is a seasoned professional in the biotech and pharmaceutical sectors, serving as Co-founder and Managing Partner of 3D-PharmXchange since 2010, where integrated drug development and project management solutions are provided. Inez has also been the CEO of Treeway since 2013, focusing on therapies for neurodegenerative diseases such as ALS and Alzheimer's Disease. In addition, Inez holds a Fellow position at the Netherlands Academy of Engineering, contributes to various advisory boards including the Member Advisory Board Topsector Life Science Health, and participates in the Industry Advisory Board of HEALTH-RI, fostering innovation in healthcare through data utilization. With a strong educational background including a PhD in Pharmacology from Leiden University, Inez has played a pivotal role in advancing research funding and collaboration through various initiatives and committees, including the ALS Research Forum and the ALS Investment Fund.
This person is not in any teams
Treeway
Treeway is a clinical-stage biotech company developing therapy for ALS, Alzheimer's Disease and other neurodegenerative diseases. Treeway has been formed by the words tree of life and pathway of a disease, for the founders the symbolic way towards a cure. We foresee that medication, research and care will change dramatically in the coming decades and patients will become an essential part of this process on their pursuit for cures in rare and common diseases. Everyone can make a difference and our slogan "one man can and will find a way, why not be that man?" underpins our drive.